Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

[1]  F. Goes,et al.  Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression. , 2022, Journal of affective disorders.

[2]  W. van den Brink,et al.  Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study , 2022, Frontiers in Psychiatry.

[3]  W. van den Brink,et al.  Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review , 2022, Journal of psychopharmacology.

[4]  M. Nour,et al.  The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world , 2022, Psychopharmacology.

[5]  Lucy Osler.  “An illness of isolation, a disease of disconnection”: Depression and the erosion of we-experiences , 2022, Frontiers in Psychology.

[6]  K. Stocker,et al.  Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study , 2022, Frontiers in Pharmacology.

[7]  D. Yaden,et al.  The conundrum of therapeutic intoxication , 2022, The British Journal of Psychiatry.

[8]  A. Cleare,et al.  Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review , 2022, Frontiers in Psychiatry.

[9]  R. McIntyre,et al.  Active mechanisms of ketamine-assisted psychotherapy: A systematic review. , 2022, Journal of Affective Disorders.

[10]  P. Ritvo,et al.  Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature , 2022, Journal of pain research.

[11]  Matthew W. Johnson,et al.  Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default , 2022, Frontiers in Psychology.

[12]  A. Garcia-Romeu,et al.  Toward Synergies of Ketamine and Psychotherapy , 2022, Frontiers in Psychology.

[13]  G. Mashour.  Ketamine Analgesia and Psychedelia: Can We Dissociate Dissociation? , 2022, Anesthesiology.

[14]  C. Zarate,et al.  Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis , 2022, Expert opinion on drug safety.

[15]  A. Lingford-Hughes,et al.  Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. , 2022, The American journal of psychiatry.

[16]  M. van Tol,et al.  Trapped: rigidity in psychiatric disorders. , 2021, The lancet. Psychiatry.

[17]  J. Moncrieff,et al.  Esketamine: uncertain safety and efficacy data in depression , 2021, The British Journal of Psychiatry.

[18]  C. Morgan,et al.  “This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders , 2021, Frontiers in Psychiatry.

[19]  Nelson B Rodrigues,et al.  Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders , 2021, CNS Drugs.

[20]  J. Joormann,et al.  Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial , 2021, Psychotherapy and Psychosomatics.

[21]  R. Schoevers,et al.  Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review , 2021, The international journal of neuropsychopharmacology.

[22]  R. Chambers,et al.  Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice. , 2021, ACS pharmacology & translational science.

[23]  C. Griffiths,et al.  A qualitative study of patients' experience of ketamine treatment for depression: The ‘Ketamine and me’ project , 2021, Journal of Affective Disorders Reports.

[24]  S. Muthukumaraswamy,et al.  A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties , 2021, Journal of psychopharmacology.

[25]  T. Wykes,et al.  Ketamine treatment for depression: qualitative study exploring patient views , 2021, BJPsych Open.

[26]  N. Haug,et al.  Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial , 2020, Journal of psychopharmacology.

[27]  K. Hawton,et al.  Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences , 2020, BJPsych Open.

[28]  F. Levin,et al.  Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study , 2020, The American journal of drug and alcohol abuse.

[29]  Cheng-Ta Li,et al.  Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression. , 2020, The Journal of clinical psychiatry.

[30]  B. Pradhan,et al.  Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction , 2020, Cureus.

[31]  C. Morgan,et al.  Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review , 2020, Behavioural Brain Research.

[32]  E. Storch,et al.  The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. , 2020, Journal of affective disorders.

[33]  K. Hawton,et al.  Effects of ketamine treatment on suicidal ideation: a qualitative study of patients’ accounts following treatment for depression in a UK ketamine clinic , 2019, BMJ Open.

[34]  M. Pavlicova,et al.  A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial. , 2019, The American journal of psychiatry.

[35]  Frederick S. Barrett,et al.  Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function , 2019, Pharmacology & therapeutics.

[36]  C. Otte,et al.  Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder , 2019, European Neuropsychopharmacology.

[37]  Nicole Strauss,et al.  Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy , 2019, Journal of psychoactive drugs.

[38]  E. Nunes,et al.  A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study , 2018, Neuropharmacology.

[39]  E. Ballard,et al.  Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. , 2018, Journal of affective disorders.

[40]  Robin L Carhart-Harris,et al.  Psychedelics and the essential importance of context , 2018, Journal of psychopharmacology.

[41]  L. Davidson,et al.  Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale. , 2018, Journal of affective disorders.

[42]  M. Torjman,et al.  Trauma Interventions using Mindfulness Based Extinction and Reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on post-traumatic stress disorder and comorbid depression: a pilot randomized, placebo-controlled, crossover clinical trial , 2017 .

[43]  S. Wilkinson,et al.  Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression , 2017, Psychotherapy and Psychosomatics.

[44]  Matthew W. Johnson,et al.  The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms , 2016, Journal of psychopharmacology.

[45]  M. Nour,et al.  Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI) , 2016, Front. Hum. Neurosci..

[46]  K. Kendler.  The Phenomenology of Major Depression and the Representativeness and Nature of DSM Criteria. , 2016, The American journal of psychiatry.

[47]  Raissa Miller,et al.  Experiences Learning Interpersonal Neurobiology: An Interpretative Phenomenological Analysis , 2016 .

[48]  Matthew W. Johnson,et al.  Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin , 2015, Journal of psychopharmacology.

[49]  A. Niemeijer.  VU Research Portal Exploring good care with surveillance technology in residential care for vulnerable people , 2014 .

[50]  Bridget C. O’Brien,et al.  Standards for Reporting Qualitative Research: A Synthesis of Recommendations , 2014, Academic medicine : journal of the Association of American Medical Colleges.

[51]  D. Luckenbaugh,et al.  Do the dissociative side effects of ketamine mediate its antidepressant effects? , 2014, Journal of affective disorders.

[52]  L. Finlay.  Engaging Phenomenological Analysis , 2014 .

[53]  E. Nunes,et al.  Therapeutic infusions of ketamine: do the psychoactive effects matter? , 2014, Drug and alcohol dependence.

[54]  Matthew W. Johnson,et al.  Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. , 2012, Journal for the scientific study of religion.

[55]  F. Vollenweider,et al.  Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV) , 2010, PloS one.

[56]  R. Griffiths,et al.  Human hallucinogen research: guidelines for safety , 2008, Journal of psychopharmacology.

[57]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[58]  Jonathan A. Smith.  Qualitative Psychology: A Practical Guide to Research Methods , 2006, QMiP Bulletin.

[59]  Jonathan A. Smith.  Reflecting on the development of interpretative phenomenological analysis and its contribution to qualitative research in psychology , 2004 .

[60]  B. Eisner.  Set, setting, and matrix. , 1997, Journal of psychoactive drugs.

[61]  E. Krupitsky,et al.  Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. , 1997, Journal of psychoactive drugs.

[62]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[63]  E. Khorramzadeh,et al.  The use of ketamine in psychiatry. , 1973, Psychosomatics.

[64]  E F Domino,et al.  Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581 , 1966, Anesthesia and analgesia.

[65]  E. Domino,et al.  Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man , 1965, Clinical pharmacology and therapeutics.

[66]  OUP accepted manuscript , 2022, The International Journal of Neuropsychopharmacology.

[67]  Dawn Joseph,et al.  Qualitative research methods in mental health and psychotherapy: A guide for students and practitioners , 2011, QMiP Bulletin.

[68]  Raissa Miller.  Interpretative Phenomenological Analysis : A Contemporary Phenomenological Approach , 2019 .

[69]  C. Schmahl,et al.  Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale. , 2018, The American journal of psychiatry.

[70]  Matthew W. Johnson,et al.  The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin , 2015 .

[71]  Jonathan A. Smith,et al.  A practical guide to using Interpretative Phenomenological Analysis in qualitative research psychology , 2014 .

[72]  J. Horáček,et al.  Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. , 2013, Neuro endocrinology letters.

[73]  Juliet M. Corbin,et al.  Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory , 2008 .

[74]  P. Cardon,et al.  A qualitative study. , 2001 .

[75]  S. Southwick,et al.  Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS) , 1998, Journal of traumatic stress.

[76]  Anselm L. Strauss,et al.  Basics of qualitative research : techniques and procedures for developing grounded theory , 1998 .